elisa kit (R&D Systems)
Structured Review

Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 133 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/quantiglo+endothelin+1+elisa+kit/Human+Endothelin-1+QuantiGlo+ELISA+Kit/pmc13058453-100-9-12
Average 94 stars, based on 133 article reviews
Images
1) Product Images from "Post-mortem evidence of pathogenic angiogenesis and abnormal vascular function in early Alzheimer’s disease"
Article Title: Post-mortem evidence of pathogenic angiogenesis and abnormal vascular function in early Alzheimer’s disease
Journal: Brain
doi: 10.1093/brain/awaf394
Figure Legend Snippet: Elevated VEGF-A and EDN1 associated with cerebral hypoperfusion in early-stage Alzheimer's disease. Concentrations of ( A ) VEGF-A and ( B ) EDN1, measured by sandwich ELISA, in Braak tangle stage groups BS0–II, BSIII–IV and BSV–VI, across brain regions. Each data-point represents the average of a duplicate measurement in a single brain region. Z -scores were calculated to combine data from two independent cohorts. Mean ± standard error of the mean are shown. Correlation analysis between ( C ) VEGF-A and ( D ) EDN1 with the MAG:PLP1 ratio in the different brain regions. Solid linear regression lines are used to indicate brain regions with significant correlations, dashed lines indicate brain regions with non-significant relationships. Trigone is not shown as it did not fit within the range of the graph. * P < 0.05, ** P < 0.01, *** P < 0.001 indicate statistical strength of correlations within respective brain regions.
Techniques Used: Sandwich ELISA
Figure Legend Snippet: Mediators of angiogenesis are dysregulated in early-stage/intermediate pathology Alzheimer's disease. ( A and B ) Levels of endoglin (CD105), a marker of neoangiogenesis, measured first using the angiogenesis proteome profiler and then independently by commercial ELISA kit. Mean and standard error of the mean are shown. * P < 0.05, ** P < 0.01. ( C and D ) Levels of pro-angiogenic ( C ) and anti-angiogenic ( D ) mediators in early-stage/intermediate pathology [Braak tangle stage (BS) III–IV] (blue) and late-stage AD (BSV–VI) (red), relative to the levels in minimal pathology BS0–II cases.
Techniques Used: Marker, Enzyme-linked Immunosorbent Assay
Related Articles
Clinical Proteomics:Article Title: Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes Article Snippet: .. ET-1 levels in the plasma of both linagliptin treated and untreated Wistar and GK rats were assessed using the Enzyme-linked Immunosorbent Assay:Article Title: Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes Article Snippet: .. ET-1 levels in the plasma of both linagliptin treated and untreated Wistar and GK rats were assessed using the |